{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:32:45Z","timestamp":1790843565289,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T00:00:00Z","timestamp":1584662400000},"content-version":"am","delay-in-days":354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.therap.2018.09.072","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T02:38:25Z","timestamp":1540435105000},"page":"215-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":139,"title":["French administrative health care database (SNDS): The value of its enrichment"],"prefix":"10.1016","volume":"74","author":[{"given":"Lucie-Marie","family":"Scailteux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Droitcourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Balusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Kerbrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Dupuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwan","family":"Drezen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Happe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Oger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.therap.2018.09.072_bib0320","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/pds.4233","article-title":"The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology","volume":"26","author":"Bezin","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.therap.2018.09.072_bib0325","series-title":"Loi no\u030a 2016-41 du 26 janvier 2016 de modernisation de notre syst\u00e8me de sant\u00e9","year":"2018"},{"key":"10.1016\/j.therap.2018.09.072_bib0330","series-title":"Arr\u00eat\u00e9 du 22 mars 2017 relatif au r\u00e9f\u00e9rentiel de s\u00e9curit\u00e9 applicable au Syst\u00e8me national des donn\u00e9es","year":"2017"},{"issue":"10","key":"10.1016\/j.therap.2018.09.072_bib0335","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.revmed.2016.01.011","article-title":"Les donn\u00e9es des certificats de d\u00e9c\u00e8s en France\u00a0: processus deproduction et principaux types d\u2019analyse","volume":"37","author":"Rey","year":"2016","journal-title":"Rev Med Interne"},{"issue":"1","key":"10.1016\/j.therap.2018.09.072_bib0340","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/fcp.12323","article-title":"From medico-administrative databases analysis to care trajectories analytics: an example with the French SNDS","volume":"32","author":"Drezen","year":"2018","journal-title":"Fundam Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.therap.2018.09.072_bib0345","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/fcp.12324","article-title":"A visual approach of care pathways from the French nationwide SNDS database - from population to individual records: the ePEPS toolbox","volume":"32","author":"Happe","year":"2018","journal-title":"Fundam Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.therap.2018.09.072_bib0350","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/pds.3879","article-title":"Brand name to generic substitution of antiepileptic drugs does not lead to seizure-related hospitalization: a population-based case-crossover study","volume":"24","author":"Polard","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"10.1016\/j.therap.2018.09.072_bib0355","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00228-013-1614-5","article-title":"Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France","volume":"70","author":"Bezin","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.therap.2018.09.072_bib0360","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00228-017-2406-0","article-title":"Antipsychotics use: 2006\u20132013 trends in prevalence and incidence and characterization of users","volume":"74","author":"Montastruc","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.therap.2018.09.072_bib0365","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.revmed.2014.11.009","article-title":"French health insurance databases: what interest for medical research?","volume":"36","author":"Moulis","year":"2015","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.therap.2018.09.072_bib0370","first-page":"1040","article-title":"Integration of clinical and genetic data in the i2b2 architecture","author":"Murphy","year":"2006","journal-title":"AMIA Annu Symp Proc AMIA Symp"},{"issue":"2","key":"10.1016\/j.therap.2018.09.072_bib0375","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/jamia.2009.000893","article-title":"Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2)","volume":"17","author":"Murphy","year":"2010","journal-title":"J Am Med Inform Assoc JAMIA"},{"key":"10.1016\/j.therap.2018.09.072_bib0380","series-title":"Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers in studies in health technology and informatics","author":"Hripcsak","year":"2015"},{"key":"10.1016\/j.therap.2018.09.072_bib0385","first-page":"584","article-title":"Roogle: an information retrieval engine for clinical data warehouse","volume":"169","author":"Cuggia","year":"2011","journal-title":"Stud Health Technol Inform"},{"key":"10.1016\/j.therap.2018.09.072_bib0390","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jbi.2018.02.019","article-title":"A clinician friendly data warehouse oriented toward narrative reports: Dr Warehouse","volume":"80","author":"Garcelon","year":"2018","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.therap.2018.09.072_bib0395","first-page":"702","article-title":"Semantic integration of medication data into the EHOP Clinical Data Warehouse","volume":"210","author":"Delamarre","year":"2015","journal-title":"Stud Health Technol Inform"},{"issue":"9","key":"10.1016\/j.therap.2018.09.072_bib0400","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/cncr.30506","article-title":"Discerning the survival advantage among patients with prostate cancer who undergo radical prostatectomy or radiotherapy: the limitations of cancer registry data","volume":"123","author":"Williams","year":"2017","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.therap.2018.09.072_bib0405","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.eururo.2017.12.009","article-title":"Re: Morbidity and mortality of locally advanced prostate cancer: a population based analysis comparing radical prostatectomy versus external beam radiation","volume":"73","author":"Roach","year":"2018","journal-title":"Eur Urol"},{"issue":"12","key":"10.1016\/j.therap.2018.09.072_bib0410","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s10654-015-0096-4","article-title":"CONSTANCES team. The French CONSTANCES population-based cohort: design, inclusion and follow-up","volume":"30","author":"Zins","year":"2015","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"10.1016\/j.therap.2018.09.072_bib0415","doi-asserted-by":"crossref","first-page":"e0194831","DOI":"10.1371\/journal.pone.0194831","article-title":"Obesity and emergency care in the French CONSTANCES cohort","volume":"13","author":"Feral-Pierssens","year":"2018","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.therap.2018.09.072_bib0420","doi-asserted-by":"crossref","first-page":"6569","DOI":"10.1038\/s41598-018-24822-0","article-title":"Unhealthy behaviours and risk of visual impairment: the CONSTANCES population-based cohort","volume":"8","author":"Merle","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.therap.2018.09.072_bib0425","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijcard.2018.02.033","article-title":"Cardiovascular risk goes up as your mood goes down: interaction of depression and socioeconomic status in determination of cardiovascular risk in the CONSTANCES cohort","volume":"262","author":"Wiernik","year":"2018","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.therap.2018.09.072_bib0430","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/jrh.12098","article-title":"A comparison of health, health behavior, and access between farm and non farm populations in rural New York state","volume":"31","author":"Earle-Richardson","year":"2015","journal-title":"J Rural Health"},{"issue":"1","key":"10.1016\/j.therap.2018.09.072_bib0435","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pop.2016.09.003","article-title":"Primary care issues in rural populations","volume":"44","author":"Deligiannidis","year":"2017","journal-title":"J Prim Care"},{"key":"10.1016\/j.therap.2018.09.072_bib0440","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejca.2017.03.002","article-title":"Androgen deprivation therapy and cardiovascular risk: no meaningful difference between GnRH antagonist and agonists-a nationwide population-based cohort study based on 2010\u20132013 French Health Insurance data","volume":"77","author":"Scailteux","year":"2017","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.therap.2018.09.072_bib0445","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/fcp.12320","volume":"32","author":"Scailteux","year":"2018","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.therap.2018.09.072_bib0450","article-title":"Use of 5\u03b1-reductase inhibitors for benign prostate hypertrophy and risk of high grade prostate cancer: a French population-based study","author":"Scailteux","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.therap.2018.09.072_bib0455","series-title":"Major bleeding risk associated with antithrombotics - the SACHA study (Survey of acute haemorrhage with antithrombotic drugs)","year":"2013"},{"issue":"2","key":"10.1016\/j.therap.2018.09.072_bib0460","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.thromres.2005.06.015","article-title":"Accuracy of coding for possible warfarin complications in hospital discharge abstracts","volume":"118","author":"Arnason","year":"2006","journal-title":"Thromb Res"},{"issue":"11","key":"10.1016\/j.therap.2018.09.072_bib0465","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/pds.3504","volume":"22","author":"Pisa","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.therap.2018.09.072_bib0470","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.thromres.2017.10.004","article-title":"Assessment of the coding accuracy of warfarin-related bleeding events","volume":"159","author":"Delate","year":"2017","journal-title":"Thromb Res"},{"issue":"13","key":"10.1016\/j.therap.2018.09.072_bib0475","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1161\/CIRCULATIONAHA.115.015710","article-title":"Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study","volume":"132","author":"Maura","year":"2015","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.therap.2018.09.072_bib0480","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1185\/03007995.2016.1161610","article-title":"Rates of major bleeding with rivaroxaban in real-world studies of nonvalvular atrial fibrillation patients: a meta-analysis","volume":"32","author":"Weeda","year":"2016","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.therap.2018.09.072_bib0485","series-title":"Risk of suicide attempt associated with isotretinoin: a nationwide cohort and case-time-control study. 2nd European Dermato-Epidemiology (EDEN) Network \u2013 Berlin","author":"Droitcourt","year":"2018"},{"issue":"12S","key":"10.1016\/j.therap.2018.09.072_bib0490","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.annder.2017.09.036","article-title":"Le risque suicidaire est-il major\u00e9 sous isotr\u00e9tino\u00efne\u00a0? Analyse des donn\u00e9es nationales de l\u2019Assurance maladie (SNIIRAM 2009-2016) \u2013 Journ\u00e9es Dermatologiques de Paris 2017","volume":"144","author":"Droitcourt","year":"2017","journal-title":"Ann Dermatol Venerologie"},{"issue":"8","key":"10.1016\/j.therap.2018.09.072_bib0495","doi-asserted-by":"crossref","first-page":"e11984","DOI":"10.1371\/journal.pone.0011984","article-title":"Assessment of a syndromic surveillance system based on morbidity data: results from the Oscour network during a heat wave","volume":"5","author":"Josseran","year":"2010","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.therap.2018.09.072_bib0500","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2515\/therapie\/2014005","article-title":"\u00c9valuation des m\u00e9dicaments chez la femme enceinte\u00a0: \u00e0 propos de la base de donn\u00e9es fran\u00e7aise EFEMERIS","volume":"69","author":"Damase-Michel","year":"2014","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2018.09.072_bib0505","article-title":"Antidepressants during pregnancy: a French drug utilisation study in EFEMERIS cohort","author":"Hurault-Delarue","year":"2018","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"3","key":"10.1016\/j.therap.2018.09.072_bib0510","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/02770903.2016.1214731","article-title":"Prescription of asthma medications before and during pregnancy in France: an observational drug study using the EFEMERIS database","volume":"54","author":"Beau","year":"2017","journal-title":"J Asthma"},{"issue":"5","key":"10.1016\/j.therap.2018.09.072_bib0515","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/fcp.12209","article-title":"Psychomotor developmental effects of prenatal exposure to psychotropic drugs: a study in EFEMERIS database","volume":"30","author":"Hurault-Delarue","year":"2016","journal-title":"Fundam Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.therap.2018.09.072_bib0520","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.arcped.2017.02.023","article-title":"A contemporary description of French newborns\u2019 growth using the Efemeris cohort","volume":"24","author":"Beau","year":"2017","journal-title":"Arch Pediatr"},{"issue":"Pt A","key":"10.1016\/j.therap.2018.09.072_bib0525","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.phrs.2016.09.028","article-title":"Risk of infections during the first year of life after in utero exposure to drugs acting on immunity: A population-based cohort study","volume":"113","author":"Palosse-Cantaloube","year":"2016","journal-title":"Pharmacol Res"},{"issue":"5","key":"10.1016\/j.therap.2018.09.072_bib0530","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1055\/s-0037-1613887","article-title":"Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d\u2019\u00e9tude de la thrombose de Bretagne occidentale","volume":"83","author":"Oger","year":"2000","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1016\/j.therap.2018.09.072_bib0535","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/sj.bjc.6605188","article-title":"Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial","volume":"101","author":"Murtola","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.therap.2018.09.072_bib0540","doi-asserted-by":"crossref","first-page":"f3406","DOI":"10.1136\/bmj.f3406","article-title":"Use of 5\u03b1-reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control study","volume":"346","author":"Robinson","year":"2013","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.therap.2018.09.072_bib0545","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/jamainternmed.2014.1600","article-title":"5\u03b1-reductase inhibitors and risk of high-grade or lethal prostate cancer","volume":"174","author":"Preston","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"3","key":"10.1016\/j.therap.2018.09.072_bib0550","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s11239-016-1361-4","article-title":"A real world data of dabigatran etexilate: multicenter registry of oral anticoagulants in nonvalvular atrial fibrillation","volume":"42","author":"Yavuz","year":"2016","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.therap.2018.09.072_bib0555","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijcard.2016.11.117","article-title":"Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life","volume":"227","author":"Becattini","year":"2017","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.therap.2018.09.072_bib0560","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.chest.2017.02.009","article-title":"Direct oral anticoagulant- or warfarin-related major bleeding: characteristics, reversal strategies, and outcomes from a multicenter observational study","volume":"152","author":"Xu","year":"2017","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.therap.2018.09.072_bib0565","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1016\/S2352-3026(17)30054-6","article-title":"Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study","volume":"4","author":"Larsen","year":"2017","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.therap.2018.09.072_bib0570","doi-asserted-by":"crossref","first-page":"c5812","DOI":"10.1136\/bmj.c5812","article-title":"Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study","volume":"341","author":"Sundstr\u00f6m","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.therap.2018.09.072_bib0575","series-title":"Les enrichissements pr\u00e9vus pour l\u2019enqu\u00eate CARE-M\u00e9nages. Direction de la recherche, des \u00e9tudes, de l\u2019\u00e9valuation et des statistiques","author":"Carr\u00e8re","year":"2017"},{"issue":"6","key":"10.1016\/j.therap.2018.09.072_bib0580","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/fcp.12143","article-title":"Choice of ICD-10 codes for the identification of acute coronary syndrome in the French hospitalization database","volume":"29","author":"Bezin","year":"2015","journal-title":"Fundam Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.therap.2018.09.072_bib0585","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/pds.4006","article-title":"Positive predictive values of selected hospital discharge diagnoses to identify infections responsible for hospitalization in the French national hospital database","volume":"25","author":"Sahli","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10.1016\/j.therap.2018.09.072_bib0590","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/fcp.12326","article-title":"Positive predictive values of peripheral arterial and venous thrombosis codes in French hospital database","volume":"32","author":"Prat","year":"2018","journal-title":"Fundam Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.therap.2018.09.072_bib0595","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/qjmed\/91.6.445","article-title":"The general practice research database. Scientific and ethical advisory group","volume":"91","author":"Lawson","year":"1998","journal-title":"QJM"},{"key":"10.1016\/j.therap.2018.09.072_bib0600","series-title":"THIN Database","year":"2018"},{"issue":"3","key":"10.1016\/j.therap.2018.09.072_bib0605","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3917\/spub.139.0355","article-title":"Faisabilit\u00e9 et int\u00e9r\u00eat de l\u2019appariement de donn\u00e9es individuelles en m\u00e9decine g\u00e9n\u00e9rale et de donn\u00e9es de remboursement appliqu\u00e9 au diab\u00e8te et \u00e0 l\u2019hypertension art\u00e9rielle","volume":"26","author":"Perlbarg","year":"2014","journal-title":"Sante Publique"},{"key":"10.1016\/j.therap.2018.09.072_bib0610","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djy035","article-title":"Using medicare claims to examine long-term prostate cancer risk of finasteride in the prostate cancer prevention trial","author":"Unger","year":"2018","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.therap.2018.09.072_bib0615","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa030660","article-title":"The influence of finasteride on the development of prostate cancer","volume":"349","author":"Thompson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.therap.2018.09.072_bib0620","series-title":"Pr\u00e9sentation de l\u2019INDS | INDS Institut national des donn\u00e9es de sant\u00e9","year":"2018"},{"key":"10.1016\/j.therap.2018.09.072_bib0625","series-title":"Nomination de Dominique Polton en qualit\u00e9 de co-pilote du Health Data Hub | INDS Institut national des donn\u00e9es de sant\u00e9","year":"2018"},{"key":"10.1016\/j.therap.2018.09.072_bib0630","series-title":"Agn\u00e8s Buzyn lance la mission de pr\u00e9figuration du \u00ab\u00a0Health Data Hub\u00a0\u00bb un laboratoire d\u2019exploitation des donn\u00e9es de sant\u00e9","author":"Minist\u00e8re des solidarit\u00e9s et de la sant\u00e9","year":"2018"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595718302403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595718302403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T18:54:06Z","timestamp":1758567246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595718302403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0040595718302403"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2018.09.072","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"French administrative health care database (SNDS): The value of its enrichment","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2018.09.072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}